Novo Nordisk, Eli Lilly stock slides after Biden op-ed calls for lower Ozempic, Wegovy Prices

Eli Lilly, Novo Nordisk shares fall as Ozempic, Wegovy tied to rare cases of vision loss

July 3, 2024 11:49 AM EDT

Novo Nordisk (NYSE: NVO) shares are down almost 4%, while Eli Lilly & Co. (NYSE: LLY) has dropped more than 1% Wednesday after a report from the New York Post said there is a potential link between Ozempic and a serious eye condition.

The publication, citing a new... More

Pharma selloff overdone: JPMorgan

July 3, 2024 7:43 AM EDT

JPMorgan analysts downplayed concerns over drug pricing that triggered a broad healthcare and pharmaceutical sector sell-off, calling it "overdone election noise."

"Pricing has always been a popular issue to comment on but tough to follow through, also more complicated with the Inflation Reduction Act (IRA) now," the bank stated.... More

BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

July 2, 2024 3:04 PM EDT

BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $1,001.00 price target on Eli Lilly (NYSE: LLY).

The analyst comments "Approval of donanemab (branded Kisunla) is likely to expand revenue for both Lilly and Biogen/Eisai as two players are needed to grow infrastructure.... More

Morgan Stanley on Eli Lilly (LLY): 'we expect LLY shares to trade flat to slightly up'

July 2, 2024 2:41 PM EDT

Morgan Stanley analyst Terence Flynn reiterated an Overweight rating and $1,023.00 price target on Eli Lilly (NYSE: LLY)

The analyst comments "The approval was in line with our expectations and we expect LLY shares to trade flat to slightly up as a result. For... More

Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices

July 2, 2024 8:00 AM EDT

(Updated - July 2, 2024 8:05 AM EDT)

(Updated - July 2, 2024 8:01 AM EDT)

Biden Says Novo Nordisk (NVO) Must Cut Ozempic, Wegovy Prices

Biden Comments In USA Today Op-ed With Senator Bernie... More

DNB Markets Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)

June 30, 2024 8:01 AM EDT

DNB Markets analyst Rune Majlund Dahl reiterated a Buy rating and DKK1,200.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).

... More

Novo Nordisk (NVO) call put ratio 2.7 calls to 1 put with focus on December 150 calls

June 28, 2024 10:25 AM EDT

Novo Nordisk (NYSE: NVO) 30-day option implied volatility is at 26; compared to its 52-week range of 22 to 44. Call put ratio 2.7 calls to 1 put with focus on December 150 calls.

... More

Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,100 at UBS

June 28, 2024 4:34 AM EDT

UBS analyst Jo Walton raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK1,100.00 (from DKK795.00) while maintaining a Neutral rating.... More